Treatment of sexually transmitted infections in women.
Sexually transmitted infections remain a major public health concern in the United States. An estimated 19 million infections occur each year. The economic burden imposed by sexually transmitted infections is impressive: direct medical costs are estimated to be as high as $15.5 billion annually. Women and infants disproportionately bear the long-term consequences of sexually transmitted diseases. This article briefly introduces various infections, reviews new diagnostic information, and presents the latest guidelines for therapy. All recommended and alternative regimens are drawn from the most recent Centers for Disease Control and Prevention treatment guidelines and recent updates.
Hollier
Lisa M
LM
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Texas Medical School at Houston, LBJ General Hospital, 5656 Kelley Street, Houston, TX 77026, USA. Electronic address: lisa.m.hollier@uth.tmc.edu.
Workowski
Kimberly
K
Division of Infectious Diseases, Emory University, 550 Peachtree Street, Suite 7000, GA 30308, USA; Guidelines Unit, Epidemiology and Surveillance Branch, Division of STD Prevention, Centers for Disease Control and Prevention, Mailstop E-02, 1600 Clifton Road, Atlanta, GA 30333, USA.
D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D003376:Counseling; D005260:Female; D006801:Humans; D015994:Incidence; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D012749:Sexually Transmitted Diseases / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D014481:United States / Q000453:epidemiology; D016387:Women's Health
D000890:Anti-Infective Agents